Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

The DEBBRAH Trial: Trastuzumab Deruxtecan in HER2-positive and HER2-low Breast Cancer Patients with Leptomeningeal Carcinomatosis

Marta Vaz Batista,Jose Manuel Perez-Garcia,Laia Garrigos,Jose Angel Garcia-Saenz,Patricia Cortez,Fabricio Racca,Salvador Blanch,Manuel Ruiz-Borrego,Adela Fernandez-Ortega,Maria Fernandez Abad,Vega Iranzo,Maria Gion,Griselda Martrat,Daniel Alcala-Lopez,Jhudit Perez-Escuredo,Miguel Sampayo-Cordero,Antonio Llombart-Cussac,Sofia Braga,Javier Cortes

MED（2025）

Cited 0|Views1
Key words
trastuzumab deruxtecan,leptomeningeal carcinomatosis,HER2 positive,HER2 low,advanced breast cancer,phase 2 trial
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined